Discover 2,271 paid clinical trials in Oakland, California. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 2,271
Androgen Suppression Combined With Nodal Irradiation and Dose Escalated Prostate Treatment
for
Prostate Cancer
Location: Oakland CA, San Leandro CA, San Francisco CA,
Sponsor: Canadian Cancer Trials Group
Sex: Male
Age: 18+
Code: NCT06235697
Phase3, Recruiting
Comparing Cytarabine + Daunorubicin Therapy Versus Cytarabine + Daunorubicin + Venetoclax Versus Venetoclax + Azacitidine in Younger Patients With Intermediate Risk AML (A MyeloMATCH Treatment Trial)
for
Acute Myeloid Leukemia
Location: Oakland CA, San Francisco CA, Santa Clara CA,
Sponsor: National Cancer Institute (NCI)
Sex: All
Age: 18 - 59
Code: NCT05554393
Phase2, Recruiting
A Study to Learn More About the Health of Persons With Down Syndrome After Treatment for Acute Leukemia
for
B Acute Lymphoblastic Leukemia Associated With Down Syndrome,
Location: Oakland CA, San Francisco CA, Sacramento CA, Madera CA,
Sponsor: Children's Oncology Group
Sex: All
Age: 6 - 39
Code: NCT05702645
Recruiting
The Pediatric Anesthesia Quality Improvement Project
for
Surgery, Anesthesia, Children
Location: Oakland CA, Palo Alto CA, Los Angeles CA, Phoenix AZ,
Sponsor: The Society for Pediatric Anesthesia
Sex: All
Age: 0 - 21
Code: NCT00674388
Recruiting
A Study of the Drugs Selumetinib vs. Carboplatin and Vincristine in Patients With Low-Grade Glioma
for
Low Grade Astrocytoma, Low Grade Glioma,
Location: Oakland CA, San Francisco CA, Palo Alto CA,
Sponsor: National Cancer Institute (NCI)
Sex: All
Age: 2 - 21
Code: NCT04166409
Phase3, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
Effects of Dexrazoxane Hydrochloride on Biomarkers Associated With Cardiomyopathy and Heart Failure After Cancer Treatment
for
Hodgkin Lymphoma in Remission, Leukemia in Remission,
Location: Oakland CA, Palo Alto CA, Duarte CA, Las Vegas NV,
Sponsor: Children's Oncology Group
Sex: All
Age: 0+
Code: NCT01790152
Recruiting
Inotuzumab Ozogamicin and Post-Induction Chemotherapy in Treating Patients With High-Risk B-ALL, Mixed Phenotype Acute Leukemia, and B-LLy
for
B Acute Lymphoblastic Leukemia, B Lymphoblastic Lymphoma,
Location: Oakland CA, San Francisco CA, Palo Alto CA,
Sponsor: Children's Oncology Group
Sex: All
Age: 1 - 25
Code: NCT03959085
Phase3, Recruiting
Chemotherapy for the Treatment of Patients With Newly Diagnosed Very Low-Risk and Low Risk Fusion Negative Rhabdomyosarcoma
for
Embryonal Rhabdomyosarcoma,
Location: Oakland CA, San Francisco CA, Palo Alto CA,
Sponsor: Children's Oncology Group
Sex: All
Age: 0 - 21
Code: NCT05304585
Phase3, Recruiting
A Study to Compare Two Surgical Procedures in Individuals With BRCA1 Mutations to Assess Reduced Risk of Ovarian Cancer
for
Ovarian Carcinoma
Location: Oakland CA, San Francisco CA, San Leandro CA,
Sponsor: NRG Oncology
Sex: Female
Age: 35 - 50
Code: NCT04251052
Recruiting
A Study to Evaluate the Utilization of 3D Printed Models in Pre-Operative Planning
for
Sarcoma, Ewing, Chondrosarcoma, Osteosarcoma,
Location: Oakland CA, Royal Oak MI, Columbus OH
Sponsor: Ricoh USA, Inc.
Sex: All
Age: 13+
Code: NCT06387485
Recruiting
Adding Nivolumab to Usual Treatment for People With Advanced Stomach or Esophageal Cancer, PARAMUNE Trial
for
Advanced Esophageal Adenocarcinoma,
Location: Oakland CA, San Leandro CA, San Francisco CA,
Sponsor: National Cancer Institute (NCI)
Sex: All
Age: 18+
Code: NCT06203600
Phase2, Phase3, Recruiting
Venetoclax and HMA Treatment of Older and Unfit Adults With FLT3 Mutated Acute Myeloid Leukemia (AML) (A MyeloMATCH Treatment Trial)
for
Acute Myeloid Leukemia
Location: Oakland CA, San Leandro CA, San Francisco CA,
Sponsor: National Cancer Institute (NCI)
Sex: All
Age: 18+
Code: NCT06317649
Phase2, Recruiting
A Study of Combination Chemotherapy for Patients With Newly Diagnosed DAWT and Relapsed FHWT
Location: Oakland CA, San Francisco CA, Palo Alto CA,
Sponsor: Children's Oncology Group
Sex: All
Age: 0 - 30
Code: NCT04322318
Phase2, Recruiting
MYELOMATCH: A Screening Study to Assign People With Myeloid Cancer to a Treatment Study or Standard of Care Treatment Within myeloMATCH (MyeloMATCH Screening Trial)
for
Acute Myeloid Leukemia,
Location: Oakland CA, San Leandro CA, San Francisco CA,
Sponsor: National Cancer Institute (NCI)
Sex: All
Age: 18+
Code: NCT05564390
Phase2, Recruiting
A Study of Treatment for Medulloblastoma Using Sodium Thiosulfate to Reduce Hearing Loss
for
Childhood Medulloblastoma
Location: Oakland CA, San Francisco CA, Sacramento CA, Madera CA,
Sponsor: Children's Oncology Group
Sex: All
Age: 4 - 21
Code: NCT05382338
Phase3, Recruiting
Adding the Immunotherapy Drug Cemiplimab to Usual Treatment for People With Advanced Non-Small Cell Lung Cancer Who Had Previous Treatment With Platinum Chemotherapy and Immunotherapy (An Expanded Lung-MAP Treatment Trial)
for
Recurrent Lung Non-Small Cell Carcinoma,
Location: Oakland CA, San Leandro CA, San Francisco CA,
Sponsor: SWOG Cancer Research Network
Sex: All
Age: 18+
Code: NCT06616584
Phase2, Phase3, Recruiting
Testing Shorter Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients With High Risk Prostate Cancer
for
Prostate Adenocarcinoma, Stage III Prostate Cancer AJCC v8,
Location: Oakland CA, San Leandro CA, San Francisco CA,
Sponsor: NRG Oncology
Sex: Male
Age: 18+
Code: NCT05946213
Phase3, Recruiting
Testing the Addition of BMS-986016 (Relatlimab) to the Usual Immunotherapy After Initial Treatment for Recurrent or Metastatic Nasopharyngeal Cancer
for
Metastatic Nasopharyngeal Carcinoma,
Location: Oakland CA, San Leandro CA, San Francisco CA,
Sponsor: National Cancer Institute (NCI)
Sex: All
Age: 18+
Code: NCT06029270
Phase2, Recruiting
Testing the Role of DNA Released From Tumor Cells Into the Blood in Guiding the Use of Immunotherapy After Surgical Removal of the Bladder, Kidney, Ureter, and Urethra for Urothelial Cancer Treatment, MODERN Study
for
Muscle Invasive Bladder Urothelial Carcinoma,
Location: Oakland CA, San Leandro CA, San Francisco CA,
Sponsor: National Cancer Institute (NCI)
Sex: All
Age: 18+
Code: NCT05987241
Phase2, Phase3, Recruiting
The Pediatric Acute Leukemia (PedAL) Screening Trial - A Study to Test Bone Marrow and Blood in Children With Leukemia That Has Come Back After Treatment or Is Difficult to Treat - A Leukemia & Lymphoma Society and Children's Oncology Group Study